The prevailing view is that high levels of cyclin D1 expression have a positive correlation with poor prognosis in a wide variety of tumors such as nasopharyngeal carcinoma (NPC) (24), gastric cancer tissues (25), and squamous cell carcinoma of the head and neck (12, 26). This evidence concerns the gene CCND1 and nasopharyngeal carcinoma.